Evergreen Capital Management LLC Pfizer Inc Transaction History

Evergreen Capital Management LLC

$2.75 Billion
Q3 2024

A detailed history of Evergreen Capital Management LLC transactions in Pfizer Inc stock. As of the latest transaction made, Evergreen Capital Management LLC holds 323,263 shares of PFE stock, worth $8.64 Million. This represents 0.34% of its overall portfolio holdings.

Number of Shares

323,263

Previous 286,947 12.66%

Holding current value

$8.64 Million

Previous $8.03 Million 16.53%

% of portfolio

0.34%

Previous 0.31%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$27.7 - $31.39 $1.01 Million - $1.14 Million	36,316 Added 12.66%	323,263 $9.36 Million
Q2 2024 Aug 14, 2024	BUY	$25.26 - $29.6 $1.24 Million - $1.45 Million	48,903 Added 20.54%	286,947 $8.03 Million
Q1 2024 May 15, 2024	SELL	$25.89 - $29.73 $67,029 - $76,970	-2,589 Reduced 1.08%	238,044 $6.61 Million
Q4 2023 Feb 14, 2024	SELL	$26.13 - $33.94 $772,794 - $1 Million	-29,575 Reduced 10.95%	240,633 $6.93 Million
Q3 2023 Nov 14, 2023	SELL	$32.09 - $37.51 $242,375 - $283,313	-7,553 Reduced 2.72%	270,208 $8.96 Million
Q2 2023 Aug 14, 2023	BUY	$36.12 - $41.79 $417,836 - $483,426	11,568 Added 4.35%	277,761 $10.2 Million
Q1 2023 May 15, 2023	BUY	$39.39 - $51.28 $3.29 Million - $4.28 Million	83,462 Added 45.67%	266,193 $10.9 Million
Q4 2022 Feb 14, 2023	BUY	$41.75 - $54.5 $126,210 - $164,753	3,023 Added 1.68%	182,731 $9.37 Million
Q3 2022 Nov 14, 2022	SELL	$43.76 - $53.42 $1.26 Million - $1.54 Million	-28,877 Reduced 13.84%	179,708 $7.86 Million
Q2 2022 Aug 15, 2022	SELL	$46.53 - $55.17 $3.33 Million - $3.94 Million	-71,481 Reduced 25.52%	208,585 $10.9 Million
Q1 2022 May 16, 2022	SELL	$45.75 - $56.69 $140,772 - $174,435	-3,077 Reduced 1.09%	280,066 $14.5 Million
Q4 2021 Mar 11, 2022	BUY	$41.32 - $61.25 $168,296 - $249,471	4,073 Added 1.46%	283,143 $16.7 Million
Q3 2021 Nov 15, 2021	BUY	$39.25 - $50.42 $820,168 - $1.05 Million	20,896 Added 8.09%	279,070 $12 Million
Q2 2021 Aug 16, 2021	BUY	$35.91 - $40.68 $492,613 - $558,048	13,718 Added 5.61%	258,174 $10.1 Million
Q1 2021 May 17, 2021	BUY	$33.49 - $37.77 $662,733 - $747,430	19,789 Added 8.81%	244,456 $8.86 Million
Q4 2020 Feb 16, 2021	BUY	$33.47 - $42.56 $717,295 - $912,103	21,431 Added 10.54%	224,667 $8.27 Million
Q3 2020 Nov 16, 2020	BUY	$31.75 - $37.25 $55,657 - $65,299	1,753 Added 0.87%	203,236 $7.46 Million
Q2 2020 Aug 14, 2020	BUY	$30.12 - $36.54 $2.49 Million - $3.02 Million	82,632 Added 69.53%	201,483 $6.59 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $1.51 Million - $2.16 Million	55,856 Added 88.67%	118,851 $3.88 Million
Q4 2019 Feb 14, 2020	BUY	$32.92 - $37.36 $479,084 - $543,700	14,553 Added 30.04%	62,995 $2.47 Million
Q3 2019 Nov 14, 2019	SELL	$32.49 - $42.13 $56,467 - $73,221	-1,738 Reduced 3.46%	48,442 $1.74 Million
Q2 2019 Aug 14, 2019	BUY	$36.98 - $41.52 $26,440 - $29,686	715 Added 1.45%	50,180 $2.17 Million
Q1 2019 May 10, 2019	BUY	$37.5 - $41.2 $77,737 - $85,407	2,073 Added 4.37%	49,465 $2.1 Million
Q4 2018 Feb 14, 2019	SELL	$38.47 - $43.86 $790,404 - $901,147	-20,546 Reduced 30.24%	47,392 $2.07 Million
Q3 2018 Nov 13, 2018	SELL	$34.47 - $41.81 $225,950 - $274,064	-6,555 Reduced 8.8%	67,938 $2.99 Million
Q2 2018 Aug 13, 2018	SELL	$32.98 - $35.16 $84,329 - $89,904	-2,557 Reduced 3.32%	74,493 $2.7 Million
Q1 2018 May 10, 2018	BUY	$31.91 - $37.02 $10,881 - $12,623	341 Added 0.44%	77,050 $2.74 Million
Q4 2017 Feb 14, 2018	SELL	$33.26 - $35.29 $507,281 - $538,243	-15,252 Reduced 16.59%	76,709 $2.78 Million
Q3 2017 Nov 09, 2017	BUY	$31.0 - $34.15 $2.85 Million - $3.14 Million	91,961	91,961 $3.28 Million

Others Institutions Holding PFE

# of Institutions

3,260

Shares Held

3.61B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $150B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Evergreen Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evergreen Capital Management LLC with notifications on news.

Account

Evergreen Capital Management LLC Pfizer Inc Transaction History